Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Akari Therapeutics PLC (AKTX)

NASDAQ NMS - GLOBAL MARKET · Biotechnology

$8.43-0.03 (-0.35%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$9.7M
P/E (TTM)
EPS
Div Yield
52W Range
Beta

Company overview

No company overview is available for Akari Therapeutics PLC yet.

Peers in Biotechnology

All in industry →

Recent press releases

Akari Therapeutics PLC has not issued a press release in this window.

SEC filings

All filings →

Akari Therapeutics PLC has not filed an SEC document in this window.

Akari Therapeutics PLC has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
2,723,966 sh● NEW
822,468 sh0.0%
146,024 sh0.0%
308,340 sh● NEW
79,236 sh0.0%
71,644 sh● NEW
69,248 sh● NEW
23,643 sh0.0%

People at Akari Therapeutics PLC

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$3.7M
06/25
NI -$1.9M
09/25
NI -$6.4M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline